Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.36
+0.05 (0.94%)
At close: Jul 18, 2025, 4:00 PM
5.36
0.00 (0.00%)
After-hours: Jul 18, 2025, 6:30 PM EDT
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $53.43 million as of July 18, 2025. Its market cap has decreased by -30.55% in one year.
Market Cap
53.43M
Enterprise Value
50.37M
1-Year Change
-30.55%
Ranking
Category
Stock Price
5.36
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $53.43M, a decrease of -57.30%. That is a compound annual growth rate of -47.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 52.93M | 12.48% |
| Dec 31, 2024 | 47.05M | -62.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.03B |
| Johnson & Johnson | 396.47B |
| AbbVie | 336.64B |
| Novo Nordisk | 301.36B |
| UnitedHealth Group | 265.33B |
| Novartis AG | 233.75B |
| Abbott Laboratories | 229.21B |
| AstraZeneca | 217.77B |